Background: Doubts have been expressed in literature whether the new revised DSM-5 category of Somatic Symptom Disorder (SSD) may meet the basic requirements of clinical utility in the identification of the psychological factors influencing the course of medical disorders. The aim was to investigate the ability of SSD and DCPR-R criteria to identify patients with more severe manifestations of Irritable Bowel Syndrome (IBS) symptoms who are often seen by clinicians as difficult patients. To our knowledge this is the first study investigating SSD and DCPR-R in severe IBS and therefore no a priori expectation could be stated. Methods: Consecutive 203 IBS patients were recruited. They were evaluated for SSD by the combined use of PHQ-15 and WI-7, DCPR-R syndromes with the related semi-structured interview, severity of IBS with the IBS-SSS scale, psychological distress with the HADS, and psychosocial functioning with the SF-12. Results: Twenty-seven percent of patients fulfilled criteria for SSD, 90% for at least one DCPR-R (mainly alexithymia, persistent somatization, demoralization, and allostatic load), and 20% for both DCPR-R and SSD. The presence of DCPR-R alexithymia and persistent somatization were associated with IBS severity with large effect size (d=1.18) that was even more than with the joint presence of SSD (d=1.07). Conclusions: Betweengroup comparison and multivariate regression showed DCPRR alexithymia and persistent somatization, but not SSD, predicted more severe forms of IBS, after controlling for psychological distress and psychosocial functioning.

DCPR-R and Somatic Symptom Disorder in Patients with Severe Irritable Bowel Syndrome / Conti, C.; Lanzara, R.; Porcelli, P.. - In: PSYCHOTHERAPY AND PSYCHOSOMATICS. - ISSN 1423-0348. - (2019). (Intervento presentato al convegno 25th World Congress of the International college of Psychosomatic Medicine, 2019 tenutosi a Florence, Italy).

DCPR-R and Somatic Symptom Disorder in Patients with Severe Irritable Bowel Syndrome

Lanzara R.;Porcelli P.
2019

Abstract

Background: Doubts have been expressed in literature whether the new revised DSM-5 category of Somatic Symptom Disorder (SSD) may meet the basic requirements of clinical utility in the identification of the psychological factors influencing the course of medical disorders. The aim was to investigate the ability of SSD and DCPR-R criteria to identify patients with more severe manifestations of Irritable Bowel Syndrome (IBS) symptoms who are often seen by clinicians as difficult patients. To our knowledge this is the first study investigating SSD and DCPR-R in severe IBS and therefore no a priori expectation could be stated. Methods: Consecutive 203 IBS patients were recruited. They were evaluated for SSD by the combined use of PHQ-15 and WI-7, DCPR-R syndromes with the related semi-structured interview, severity of IBS with the IBS-SSS scale, psychological distress with the HADS, and psychosocial functioning with the SF-12. Results: Twenty-seven percent of patients fulfilled criteria for SSD, 90% for at least one DCPR-R (mainly alexithymia, persistent somatization, demoralization, and allostatic load), and 20% for both DCPR-R and SSD. The presence of DCPR-R alexithymia and persistent somatization were associated with IBS severity with large effect size (d=1.18) that was even more than with the joint presence of SSD (d=1.07). Conclusions: Betweengroup comparison and multivariate regression showed DCPRR alexithymia and persistent somatization, but not SSD, predicted more severe forms of IBS, after controlling for psychological distress and psychosocial functioning.
2019
25th World Congress of the International college of Psychosomatic Medicine, 2019
DCPR; IBS; somatic symptom disorder
04 Pubblicazione in atti di convegno::04c Atto di convegno in rivista
DCPR-R and Somatic Symptom Disorder in Patients with Severe Irritable Bowel Syndrome / Conti, C.; Lanzara, R.; Porcelli, P.. - In: PSYCHOTHERAPY AND PSYCHOSOMATICS. - ISSN 1423-0348. - (2019). (Intervento presentato al convegno 25th World Congress of the International college of Psychosomatic Medicine, 2019 tenutosi a Florence, Italy).
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1399098
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact